Population Groups: Clinical Trials

21 trials of Population Groups, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 5 recruiting, 5 unknown, 3 not yet recruiting. 21 Phase 3, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 321Completed 8, Recruiting 5, Unknown 5, Not yet recruiting 3
Phase 25Completed 2, Not yet recruiting 1, Recruiting 1, Unknown 1

Follow Population Groups: new trials by email Literature Review of Population Groups trials Research Report on Population Groups

Trials (filtered) newest first · largest first

All 21 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)
UBT251 Injection 2.0 mg group, UBT251 Injection 4.0 mg group, UBT251 Injection 6.0 mg group - Type 2 Diabetes
Phase 3RecruitingThe United Bio-Technology (Hengqin) Co., Ltd.9562026-09-072026-09-14
A Study of the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe Depression
Placebo group, JS1-1-01 low-dose group, JS1-1-01 high-dose group - Depression
Phase 2 / Phase 3Not yet recruitingTasly Pharmaceutical Group Co., Ltd1802026-04-302026-04-08
A Study to Evaluate the Efficacy and Safety of Different Doses of CB03-154 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)
Test drug CB03-154 5mg group, Test drug CB03-154 10mg group, Test drug CB03-154 15mg group - ALS (Amyotrophic Lateral Sclerosis)
Phase 2 / Phase 3RecruitingShanghai Zhimeng Biopharma, Inc.2402025-10-302026-09-22
Timing of Aminophylline and Recovery in Pediatric Ambulatory Surgery
Group (E): receive aminophylline early intraoperatively,, Group (L) received aminophylline late intraoperatively, Group (C) will receive normal saline post-anesthetic discontinuation. - Postoperative Recovery, Pediatric Anesthesia
Phase 3CompletedHany Mohammed El-Hadi Shoukat Mohammed602025-06-152026-06-16
Intrathecal DEX With Bupivacaine Inpost-spinal Shivering After CS.
dexmedetomidine 3mcg group, dexmedetomidine 5mcg, preservative-free 0.9% saline. - Post Spinal Anesthesia Shivering
Phase 3Not yet recruitingAl-Azhar University402025-05-012025-04-24
A Clinical Trial to Evaluate the Efficacy and Safety of Methoxyethyl Etomidate Hydrochloride for Sedation/Anesthesia During Gastroscopy/Colonoscopy
ET-26HCl 0.8mg/kg group, Etomidate Injectable Product 0.3mg/kg group - Gastroscopy, Colonoscopy
Phase 3Not yet recruitingAhon Pharmaceutical Co., Ltd.2702025-03-012025-03-05
Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis
VC005 low dose group, VC005 high dose group, VC005 Placebo group - Moderate to Severe Atopic Dermatitis
Phase 3RecruitingJiangsu vcare pharmaceutical technology co., LTD4802024-12-302026-07-27
Amniotic Suspension Allograft Injection for Knee Osteoarthritis
ASA injection 40 mg group, ASA injection 20 mg group, HA injection group - Knee, Osteoarthritis
Phase 3RecruitingChang Gung Memorial Hospital1602024-10-212026-01-26
Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge
Amoxicillin 250 MG, Placebo, Amoxicillin 62.5mg - Penicillin Allergy
Phase 3RecruitingJames Tarbox, MD3802024-02-032025-05-01
A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Evaluate the Clinical Efficacy and Safety of Yogliptin Tablets
placebo group, Yogliptin 400mg group, Yogliptin 200mg group - Type 2 Diabetes
Phase 3UnknownChengdu Easton Biopharmaceuticals Co,Ltd4502022-01-012022-04-20
Efficacy and Safety Study of TPN171H Tablets in Erectile Dysfunction.
TPN171H 2.5mg group, TPN171H 5mg group, TPN171H 10mg group - Erectile Dysfunction
Phase 3CompletedVigonvita Life Sciences7652021-12-312023-03-07
Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal Ulcer
LXI-15028 50mg group, Lansoprazole 30mg group - Duodenal Ulcer
Phase 3CompletedShandong Luoxin Pharmaceutical Group Stock Co., Ltd.4002021-10-182023-04-25
Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells)
Recombinant new coronavirus vaccine (CHO cell) group - Coronavirus Disease 2019
Phase 3UnknownAnhui Zhifei Longcom Biologic Pharmacy Co., Ltd.16802021-09-092021-10-25
Clinical Study of Recombinant Novel Coronavirus(COVID-19) Vaccine (CHO Cell) Combined With Influenza Vaccine
Tetravalent influenza virus lysis vaccine, Recombinant new coronavirus vaccine (CHO cell) group - Coronavirus Disease 2019
Phase 3CompletedAnhui Zhifei Longcom Biologic Pharmacy Co., Ltd.2992021-09-032023-06-08
A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19
Recombinant new coronavirus vaccine (CHO cell) group, Recombinant new coronavirus vaccine (CHO cells) placebo group - Prevention of COVID-19, Safety and Efficacy
Phase 3UnknownAnhui Zhifei Longcom Biologic Pharmacy Co., Ltd.289042020-12-162022-01-19
Comparing Efficacy of PRP Combined With Different Hyaluronan for the Treatment of Knee Osteoarthritis
PRP+Artz group, PRP+ HYAJOINT Plus group - Knee Osteoarthritis
Phase 2 / Phase 3CompletedKaohsiung Veterans General Hospital.952019-07-012021-06-18
Effect of Intracameral Steroids During Phacoemulsification on the Cornea
Control group, Dexamethasone group, Triamcinolone (TA) group - Corneal Edema
Phase 3CompletedCairo University692019-06-162022-03-08
Effect of a Topical Ketamine on Acute and Chronic Pain, Dose Finding
group (A), group (B), group (c) - Breast Cancer
Phase 2 / Phase 3CompletedAssiut University902017-06-012020-11-03
Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine
Amlodipine, amlodipine-FA tablet, low dose group, amlodipine-FA tablet ,high dose group - Essential Hypertension
Phase 2 / Phase 3UnknownShenzhen Ausa Pharmed Co.,Ltd7562013-01-012013-05-08
Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma
PF (cisplatin and 5-fluorouracil) group, TPF (docetaxel plus cisplatin and 5-fluorouracil) group - Chemoradiation, Nasopharyngeal Carcinoma
Phase 3UnknownZhejiang Cancer Hospital4002012-04-012013-03-05

Showing 20 of 21. Sign in to see all of them.

Conditions studied

COVID-19 (2)  ·  Diabetes Mellitus, Type 2 (2)  ·  Osteoarthritis (2)  ·  Osteoarthritis, Knee (2)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Breast Neoplasms (1)  ·  Corneal Edema (1)  ·  Depression (1)  ·  Drug Hypersensitivity (1)  ·  Duodenal Ulcer (1)  ·  Erectile Dysfunction (1)  ·  Essential Hypertension (1)  ·  Hyperhomocysteinemia (1)  ·  Hypertension (1)  ·  Nasopharyngeal Carcinoma (1)

Sponsors

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. (3)  ·  Ahon Pharmaceutical Co., Ltd. (1)  ·  Al-Azhar University (1)  ·  Assiut University (1)  ·  Cairo University (1)  ·  Chang Gung Memorial Hospital (1)  ·  Chengdu Easton Biopharmaceuticals Co,Ltd (1)  ·  Hany Mohammed El-Hadi Shoukat Mohammed (1)  ·  James Tarbox, MD (1)  ·  Jiangsu vcare pharmaceutical technology co., LTD (1)  ·  Kaohsiung Veterans General Hospital. (1)  ·  Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. (1)  ·  Shanghai Zhimeng Biopharma, Inc. (1)  ·  Shenzhen Ausa Pharmed Co.,Ltd (1)  ·  Tasly Pharmaceutical Group Co., Ltd (1)

Countries

China (13)  ·  Egypt (4)  ·  Taiwan (2)  ·  United States (2)  ·  Ecuador (1)  ·  Indonesia (1)  ·  Pakistan (1)  ·  Uzbekistan (1)

Top investigators

Tao Huang (2)  ·  Fangjun Li, Bachelor (1)  ·  Hui Jiang (1)  ·  James A Tarbox, MD (1)  ·  Jin Liu (1)  ·  Khaled G Abueleinen, MD, PhD (1)  ·  Lixin Guo (1)  ·  Mengchang Yang (1)  ·  Menna T'Allah A.Mahmoud Gebril, MSc (1)  ·  Neven AbdElmalk Gouda, MD (1)  ·  Osama H. Ahmed, MD (1)  ·  Rena R Wing, PhD (1)  ·  Shu-Fen Sun (1)  ·  Xiaozhong Chen, MD (1)  ·  Yong Huo, MD (1)

Results publications

PMID 11642645, PMID 15050897, PMID 21755342, PMID 22455987, PMID 25416198, PMID 26403468, PMID 27104183, PMID 27310019, PMID 27552452, PMID 27845852, PMID 28291178, PMID 3068365, PMID 30774462, PMID 30797141, PMID 32278352, PMID 33420185, PMID 33874898, PMID 3479839, PMID 35507481, PMID 36329428, PMID 39378042, PMID 42861767

NIH funding

R18DK083248 (1)